Found 1815 clinical trials
Study for Novel Coronavirus Pneumonia (NCP)
To develop practical and effective clinical diagnosis and treatment schemes for the control of novel coronavirus pneumonia.
- 0 views
- 16 Feb, 2024
- 1 location
Understanding Immunity to SARS-CoV-2 the Coronavirus Causing COVID-19
The purpose of this study is to test over time immunity to SARS-CoV-2, a recently identified coronavirus responsible for the 2019 world-wide pneumonia outbreak known as COVID-19. Adults and children diagnosed with COVID-19 as well as controls without COVID-19 will be invited to participate in this study.
- 0 views
- 16 Feb, 2024
- 1 location
Prediction of Clinical Course in COVID19 Patients
In the context of the COVID19 pandemic and containment, chest CT is currently frequently performed on admission, looking for suggestive signs and basic abnormalities of COVID19 compatible viral pneumonitis pending confirmation of identification of viral RNA by reverse-transcription polymerase chain reaction(PCR), with a reported sensitivity of 56-88% in the first …
- 0 views
- 05 Aug, 2020
A Longitudinal Study of COVID-19 Sequelae and Immunity
Some people who get COVID-19 have only mild symptoms. But for others, infection leads to pneumonia, respiratory failure, and, in some cases, death. Researchers want to learn more about any effects that may persist after people recover from COVID-19.
- 0 views
- 16 Feb, 2024
- 1 location
Direct and Indirect Impact of COVID-19 In Older Populations
This study propose to describe risk factors for acute and long term mortality of COVID 19 in patients up to 70 years old.
- 0 views
- 05 Aug, 2020
The Canadian COVID-19 Prospective Cohort Study (CANCOV)
The CANCOV study will be the first Canadian study to provide a comprehensive evaluation of early and 1-year outcomes of outpatient and hospitalized COVID-19 survivors and their family caregivers, their varied trajectories and associated clinical risk factors. The overall objectives are to determine short- (in hospital) and longer-term (1, 3, …
- 0 views
- 19 Nov, 2021
- 9 locations
Change in the Ratio of Mean Platelet Volume (MPV) to Platellet(PLT) in Covid-19 Pneumonia Patients
Previous studies claims that the proportion of mean platellet volume to platellet which can simply be determined with simple blood tests that are performed at admission, might predict the mortality in ARDS patients. Covid-19 pneumonia has a very similar clinical outlook with ARDS. Therefore we decided to research whether that …
- 0 views
- 16 Feb, 2024
- 1 location
Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of COVID-19
This is an obsevational study, the investigators collected the clinical information and clinical outcomes of the COVID-19 patients using anti-2019-nCoV inactivated convalescent plasma.The study is to evaluate the efficacy and safety of anti-2019-nCoV inactivated convalescent plasma in the treatment of COVID-19 pneumonia.
- 0 views
- 16 Feb, 2024
- 1 location
Viral Excretion in Contact Subjects at High/Moderate Risk of Coronavirus 2019-nCoV Infection. COVID-19.
In December 2019, a pneumonia due to a novel coronavirus (SARS-CoV-2) emerged in the city of Wuhan, in China. In a few weeks, the number of confirmed cases of SARS-CoV-2 infection has dramatically increased, with almost 150'000 cases and more than 6'000 reported deaths on March, 16th 2020.
- 0 views
- 16 Feb, 2024
- 17 locations
Development of a Simple Fast and Portable Recombinase Aided Amplification Assay for 2019-nCoV
In late December 2019, several local health facilities reported clusters of patients with pneumonia of unknown cause that were epidemiologically linked to a seafood and wet animal wholesale market in Wuhan, Hubei Province, China.
- 0 views
- 16 Feb, 2024
- 1 location